101 related articles for article (PubMed ID: 8142608)
1. Cross-linking of human neutrophil surface proteins to iodinated interleukin 8 or neutrophil activating peptide-2 results in at least four separable proteins.
Besemer J; Schnitzel W; Monschein U; Ryffel B
Cytokine; 1993 Sep; 5(5):512-9. PubMed ID: 8142608
[TBL] [Abstract][Full Text] [Related]
2. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
[TBL] [Abstract][Full Text] [Related]
4. Monomer-dimer equilibria of interleukin-8 and neutrophil-activating peptide 2. Evidence for IL-8 binding as a dimer and oligomer to IL-8 receptor B.
Schnitzel W; Monschein U; Besemer J
J Leukoc Biol; 1994 Jun; 55(6):763-70. PubMed ID: 8195702
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects.
Petersen F; Flad HD; Brandt E
J Immunol; 1994 Mar; 152(5):2467-78. PubMed ID: 8133058
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.
Cerretti DP; Kozlosky CJ; Vanden Bos T; Nelson N; Gearing DP; Beckmann MP
Mol Immunol; 1993 Mar; 30(4):359-67. PubMed ID: 8384312
[TBL] [Abstract][Full Text] [Related]
7. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.
Walz A; Burgener R; Car B; Baggiolini M; Kunkel SL; Strieter RM
J Exp Med; 1991 Dec; 174(6):1355-62. PubMed ID: 1744577
[TBL] [Abstract][Full Text] [Related]
8. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
[TBL] [Abstract][Full Text] [Related]
9. Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
Rennen HJ; Frielink C; Brandt E; Zaat SA; Boerman OC; Oyen WJ; Corstens FH
J Nucl Med; 2004 Jul; 45(7):1217-23. PubMed ID: 15235069
[TBL] [Abstract][Full Text] [Related]
10. [Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA.
Walz A; Meloni F; Clark-Lewis I; von Tscharner V; Baggiolini M
J Leukoc Biol; 1991 Sep; 50(3):279-86. PubMed ID: 1856598
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
12. Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression.
Ludwig A; Ehlert JE; Flad HD; Brandt E
J Immunol; 2000 Jul; 165(2):1044-52. PubMed ID: 10878382
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8.
Sticherling M; Schröder JM; Christophers E
J Immunol; 1989 Sep; 143(5):1628-34. PubMed ID: 2668411
[TBL] [Abstract][Full Text] [Related]
15. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
Eur J Immunol; 1990 Sep; 20(9):2113-8. PubMed ID: 2145175
[TBL] [Abstract][Full Text] [Related]
16. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.
Schwartzkopff F; Brandt E; Petersen F; Flad HD; Bock L; Ludwig A
J Interferon Cytokine Res; 2002 Feb; 22(2):257-67. PubMed ID: 11911809
[TBL] [Abstract][Full Text] [Related]
17. Activation of human basophils through the IL-8 receptor.
Krieger M; Brunner T; Bischoff SC; von Tscharner V; Walz A; Moser B; Baggiolini M; Dahinden CA
J Immunol; 1992 Oct; 149(8):2662-7. PubMed ID: 1383321
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release.
Petersen F; Van Damme J; Flad HD; Brandt E
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):35-41. PubMed ID: 1651769
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis.
Detmers PA; Powell DE; Walz A; Clark-Lewis I; Baggiolini M; Cohn ZA
J Immunol; 1991 Dec; 147(12):4211-7. PubMed ID: 1721641
[TBL] [Abstract][Full Text] [Related]
20. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
